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stenotic disease after percutaneous transluminal
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MD, PhD,b and F. L. Moll, MD, PhD,a Nieuwegein, The Netherlands
Purpose: The purpose of this study was to determine the long-term results (1-15 years) of percutaneous transluminal
angioplasty (PTA) of localized atherosclerotic lesions of the infrarenal aorta.
Methods: This was a retrospective study. From January 1987 to January 2002, 69 patients underwent PTA of an isolated
stenosis of the lower abdominal aorta under local anesthesia in the department of interventional radiology. All
atherosclerotic lesions were hemodynamically significant, defined as a subjective report of walking distance less than one
block, resting pain, or trophic changes in combination with diameter reduction of 50% or greater at duplex ultrasound
scanning and angiography.
Results: The female-male ratio of study patients was 3.6:1; mean age was 58 years. Endovascular treatment was initially
technically and clinically successful in all but one patient (98%), who had a near total occlusion. No major complications
were noted. Mean follow-up was 57 months (range, 6 months–15 years). At life table analysis, 5-year primary patency was
75%, and secondary patency was 97%. Twelve patients (17%) required repeat interventions because of hemodynamically
significant recurrent stenosis in combination with severe clinical symptoms. Most recurrent stenoses (67%) were
successfully treated with repeat endovascular procedures.
Conclusions: Early and long-term results of PTA (with additional stent placement) of isolated stenosis of the infrarenal
aorta are good. This minimally invasive procedure is a true alternative to traditional surgical methods. (J Vasc Surg 2004;
39:427-31.)
The infrarenal abdominal aorta and the iliac arteries are
the most common sites affected by atherosclerosis in pa-
tients with ischemic peripheral atherosclerotic disease.1 Lo-
calized stenosis or even occlusion of the infrarenal aorta
above the aortic bifurcation, however, occurs relatively
infrequently. In contrast to the male predominance in
chronic multilevel atherosclerotic disease (male-female ra-
tio, approximately 6:1), most patients with localized aortic
lesions are women aged 30 to 50 years.2 The most impor-
tant risk factors are heavy smoking, abnormal blood lipid
concentrations,3,4 and so-called hypoplastic aorta syn-
drome.5 Size criteria for aortic hypoplasia include infrarenal
aortic diameter less than 13.2 mm, or less than 10.3 mm
just above the aortic bifurcation.4 Patients with more dif-
fuse or multilevel stenotic lesions are much more likely to
have other risk factors, such as hypertension, diabetes, or
associated atherosclerotic disease of the coronary or cere-
bral arteries.
Traditionally, endarterectomy was the treatment of
choice for localized aortic stenosis. After Dotter and Jud-
kins6 introduced percutaneous transluminal angioplasty
(PTA) in 1964, balloon angioplasty became a feasible alter-
native treatment for small and medium occluded or ste-
notic arteries. Finally, with the introduction of larger bal-
loons it was possible to treat stenosis in major vessels, such
as the aorta.7,8
Many subsequent studies have demonstrated the initial
advantages of PTA over surgery, including shorter hospital
stay, lower complication rate, and less invasive technique.
However, few authors report the long-term results of PTA
(with additional stent placement) in strictly isolated infra-
renal aortic lesions. We report long-term results of PTA of
69 such lesions with follow-up to a maximum of 15 years.
PATIENTS AND METHODS
Between January 1987 and January 2002, 69 patients
were referred for percutaneous treatment of symptomatic
stenosis or occlusion of the infrarenal aorta. Pre-procedural
and post-procedural clinical symptoms were registered.
Risk factors for atherosclerosis were registered in all pa-
tients, including history of smoking (75%), hypertension
(30%), diabetes mellitus (17%), and hypercholesterolemia
(55%). Further assessment consisted of ankle-brachial index
(ABI) at rest, calculated from Doppler ultrasound pressure
measurements.
All included patients had severe clinical symptoms,
including disabling claudication (at100 m), resting pain,
or trophic changes. Patients with claudication had been
engaged in an exercise program for at least 6 months, all
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without improvement. Actual vascular risk factors were
treated medicinally.
Degree of diameter reduction of stenotic aortic lesions
was classified with duplex ultrasound (US) scan measure-
ments. Diameter reduction greater than 50% was defined as
peak systolic velocity ratio greater than 2.5, and diameter
reduction greater than 75% was defined as peak systolic
velocity ratio greater than 5.5 in combination with end-
diastolic velocity greater than 60 cm/s.9 These are adjusted
criteria that have been validated in our vascular laboratory
with angiography.
If diameter reduction exceeded 50%, in combination
with the above-mentioned clinical symptoms, digital sub-
traction angiography was performed in at least two planes.
All stenoses were localized in the infrarenal aorta and
did not extend into the aortic bifurcation. Patient selection
was performed by both vascular surgeons and interven-
tional radiologists. The number of patients with a symp-
tomatic stenotic lesion not treated with PTA is unknown,
because of the retrospective character of the study. These
patients all could walk farther than one block, started an
excercise program, and stopped smoking. If necessary, vas-
cular risk factors were lowered with medicine.
Procedure. All PTA procedures were performed with
the patient under local anesthesia in the angiography suite
in the Department of Interventional Radiology. Angio-
plasty procedures were performed by one of three staff
interventional radiologists. All PTA procedures were per-
formed through the transfemoral route with the Seldinger
technique. For stenosis just proximal to the aortic bifurca-
tion the “kissing balloon” technique was used10; otherwise
a single balloon was used.
During angioplasty additional stents were placed on the
basis of selective criteria, including (1) nearly or totally
occlusive aortic lesions; (2) persistent trans-stenotic mean
pressure gradient 10 mm Hg or greater during pharmaco-
logically induced vasodilatation, after angioplasty; (3) 30%
or greater residual stenosis; and (4) occurrence of dissec-
tion. Both balloon-expandable stents (Palmaz, Cordis;
Johnson & Johnson, Warren, NJ) and self-expanding stents
(WallStent; Boston Scientific, Schneider, Bullach, Switzer-
land) were used. The choice of type of stent depended on
personal preference of the radiologists. The size of the stent
corresponded with the measured diameter of the native
aorta just proximal or distal to the lesion, measured on the
pre-procedural angiogram, with a maximum of 10% over-
sizing.
All patients received anti-aggregant therapy (aspirin,
100 mg/d) at the time the indication for PTA was made,
which was continued for at least 6 months. Before angio-
plasty, a bolus of 5000 IU of heparin was given.
Anti-aggregant medication was continued after the
procedure; if an additional stent had been placed, dipyrid-
amole was added for 3 months.
Technical success was defined as residual radiologic
stenosis of 30% or less, with mean pressure gradient 10 mm
Hg or less across the treated site. Clinical success was
defined as a subjective perception of walking distance im-
provement, absence of resting pain, and healing of trophic
changes. Because the study was retrospective, post-proce-
dural treadmill test results are not available.
Follow-up. After angioplasty, ABI at rest was mea-
sured. Follow-up was at 3, 6, and 12 months post-proce-
dure, and yearly thereafter, and consisted of clinical exam-
ination, ABI measurement, and duplex US scanning.
Angiography was performed in patients with subjective
deterioration in walking distance (100 m), pain at rest, or
trophic changes, combined with greater than 50% recurrent
stenosis as measured on duplex US scans.
RESULTS
Pre-angioplasty data. Of the 69 study patients 54
were women (78%). Mean patient age was 58 years (range,
26-85 years). Disabling claudication was the reason for
intervention in 61 patients (88%); 4 patients (6%) had
resting pain, and another 4 patients had trophic changes.
Before angioplasty mean resting ABI was 0.76  0.16 and
0.75  0.14 on the right and left sides, respectively. Pre-
procedure angiograms showed mean aortic stenosis of 77%
(range, 58%-99%). All patients had normal iliac and distal
circulation. Average diameter of the not stenotic infrarenal
aorta was 13 mm, measured at angiography in two planes.
Procedure. With the Seldinger technique, 49 stenoses
were dilated with the single-balloon technique (Fig 1), and
15 with the so-called kissing balloon technique. Mean size
of the single balloons used was 12 4 mm. In the absence
of larger balloons before 1990, two 7-mm or 8-mm dila-
tion balloons had to be introduced through both femoral
arteries through 7F sheaths. Dilation of the lower abdom-
inal aorta could be performed only with inflation of two
balloons simultaneously. This technique was used in 5
patients (7%).
Concomitant stent placement was necessary in 24 pro-
cedures. Twenty-one stents were placed because of residual
stenosis greater than 30% after angioplasty or greater than
10 mm Hg trans-lesional pressure gradient. In 3 patients
PTA of the aorta was complicated by dissection, which was
successfully over-stented.
Early results. Endovascular treatment was initially
technically and clinically successful in all but 1 patient. This
patient had near total occlusion of the infrarenal aorta, and
it was difficult to traverse the atherosclerotic lesion with the
guide wire. The primary placed stent turned out to be
positioned subintimally, which led to early occlusion, and
an aortic bifurcation bypass graft was placed without fur-
ther complication. No procedure-related death occurred
within 30 days after initial angioplasty, nor was there any
aortic rupture.
Directly after PTA 86% of patients had an increase in
ABI of more than 0.15. Five patients had minor complica-
tions, including vasovagal collapse (n  1), groin hema-
toma (n  2), and peripheral emboli (n  1), all without
permanent sequelae.
Long-term results. No patients were lost to follow-
up. Follow-up ranged from 6 months to 15 years (average,
57 months). Kaplan-Meier life table analysis of primary and
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secondary clinical patency is shown in Figs 2 and 3. At mean
follow-up of 5 years, primary patency was 75%, and second-
ary patency was 97%. Thus most patients had no symptoms
and did not undergo repeat intervention.
Secondary patency in 7 patients with 10-year follow-up
was 87%.
During follow-up 12 patients required repeat interven-
tions, because of hemodynamically significant recurrent
stenosis. None of these patients had worse symptoms com-
pared with before initial PTA. Eight patients were success-
fully treated with repeat endovascular procedures (PTA, n
 2; PTA with additional stent placement, n  4; two
separate endovascular interventions, n  2). Four patients
required surgical intervention (aortobifemoral grafts), be-
cause of recurrent resting pain (n  2) or trophic changes
(n 2). Two patients were operated on without a renewed
endovascular intervention after restenosis had occurred and
two after repeat endovascular intervention. Surgery was
performed in cases of aortic occlusion with extension at
least into the common iliac artery. Surgical interventions
were performed at 2 months and at 4, 7, and 8 years,
respectively, after initial angioplasty.
During follow-up 3 patients died, one of pneumonia
and two of cardiac arrest. None of these deaths was related
to the angioplasty procedure.
DISCUSSION
Aortoiliac atherosclerosis limited to the distal aorta and
common iliac arteries occurs in approximately 10% of pa-
tients with symptomatic aortoiliac disease. In most of these
patients, however, atherosclerosis has not only affected the
distal abdominal aorta, but extends into the orifices of the
common iliac arteries.1,11,12 Over the last 15 years, 69 PTA
procedures to treat hemodynamically significant isolated
aortic stenosis were performed at our hospital, compared
with approximately 700 percutaneous endovascular proce-
dures to treat combined aortoiliac disease.
Similar to earlier reports, our patients were mainly
relatively young women (78%) with a high frequency of
smoking and hypercholesterolemia in combination with a
hypoplastic aorta. Life expectancy in this group of patients
is better than in the group with more diffuse atherosclerotic
disease,13 and the risk for progression of atherosclerosis is
also less likely in patients with focal aortic lesions.14 Mean
diameter of the aorta just proximal and distal to the stenotic
lesion was 13 mm, measured at angiography. This diameter
is in the lower distribution of aortic diameters, and is
associated with peripheral arterial occlusive disease.15
Traditionally, endarterectomy was the treatment of
choice for localized aortic stenosis. Good long-term results
have been published for localized endarterectomy of the
abdominal aorta (11-year cumulative patency rate of
86%16). However, operative mortality rate still is about 3%,
and morbidity is even higher. Further well-known advan-
tages of PTA are lower cost, shorter hospital stay, and
preservation of sexual function.
The overall complication rate of endarterectomy to
treat localized aortic stenosis in young patients is not dif-
ferent from that with angioplasty. More important, most
endarterectomy failures are associated with small, hypoplas-
Fig 1. Localized stenosis of infrarenal aorta before (top) and after
(bottom) angioplasty with a single-balloon technique.
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tic aortas (in both men and women), as in our patient
group.
Contrary to balloon angioplasty of the iliofemoral ar-
teries, there are few reports of PTA of isolated infrarenal
aorta stenoses. In these publications, initial clinical and
angiographic success was achieved in 90% to 95% of pa-
tients, with low major and minor complication rates.17-19
Follow-up of patients in our cohort study is longest, with
comparable initial results and good long-term results.
Since the first successful PTA of the infrarenal abdom-
inal aorta was reported, much progress has been made. In
particular, development of larger balloons has lowered the
number of complications. The larger the balloon the lower
the inflation pressure needed for the same radial force. The
10-mm to 15-mm balloons used for PTA of the aorta have
a normal dilation pressure of 4 atm, whereas the rated burst
pressure is up to 6 atm. Usually there is no need to inflate
the balloons with more than 3 to 4 atm for 1 minute. It is
important not to dilate with much higher pressure, to avoid
rupture of the aorta. Clinically, discomfort from over-
stretching the aorta is manifested as lower back or abdom-
inal pain. The potentially lethal complication of aortic
rupture20 did not occur in our patient population.
In contrast to the iliac arteries, no randomized trials
have evaluated the significance of primary stent placement
in aortic stenosis. Therasse et al21 evaluated the long-term
clinical and hemodynamic effectiveness of aortic stent
placement in cases of failure of PTA versus successful PTA,
and found no significant differences. Other studies in which
stent placement is described included patients with com-
Fig 2. Kaplan-Meier life table analysis of primary clinical patency after endovascular treatment of a solitary stenotic
lesion of the infrarenal aorta.
Fig 3. Kaplan-Meier life table analysis of secondary clinical patency after endovascular treatment of a solitary stenotic
lesion of the infrarenal aorta.
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bined aortoiliac disease. In this retrospective study, we
cannot be certain that the indications for additional stent
insertion were always right. However, none of the patients
had complications from stent placement, and the long-term
results are good.
In conclusion, PTA of isolated infrarenal aorta stenosis
is a relatively safe and minimally invasive procedure. In this
study, with the longest follow-up to date, initial and long-
term results are good. At mean follow-up of 57 months,
75% of patients had no symptoms. In most patients hemo-
dynamically significant recurrent stenosis (clinical deterio-
ration and50% stenosis according to duplex US scanning
and angiographic criteria) was effectively treated with re-
peat endovascular treatment. Eventual failure of PTA does
not preclude further treatment with surgery.
Therefore, angioplasty should be seriously considered
in treatment of localized stenosis of the infrarenal aorta.
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